SHENZHEN DIANTUN TECHNOLOGY CO.,LTD – Trademark Portfolio
Entity Type: 99
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include CEZO, INTEO, ESHOME, KOCOWO, and KINLEED. The owner is based in Shenzhen, Guangdong.
Room 725, F 7th, Bldg B, Tianhui Bldg,
Songyou Road, Longhua Street, Longhua
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does SHENZHEN DIANTUN TECHNOLOGY CO.,LTD have?
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does SHENZHEN DIANTUN TECHNOLOGY CO.,LTD file in?
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 6 (Metal Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SHENZHEN DIANTUN TECHNOLOGY CO.,LTD's most well-known trademarks?
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD's registered trademark portfolio includes well-known marks such as CEZO, INTEO, ESHOME, KOCOWO, and KINLEED. These are among 7 currently registered trademarks in the portfolio.
What is SHENZHEN DIANTUN TECHNOLOGY CO.,LTD's trademark registration success rate?
SHENZHEN DIANTUN TECHNOLOGY CO.,LTD has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.